20-year outcomes following conservative management of clinically localized prostate cancer.

By P. Albertsen, James A. Hanley, J. Fine. Journal of the American Medical Association (JAMA), 2005

1,239 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. (2015, background): “7% (Fig 2) in our study and 22% in the study by Albertsen et al.(7) There are seven active surveillance series in the literature, including this one (Table 2), constituting more than 4,000 patients.”
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. (2011, methodology): “Third, the natural history of these favourable tumours is very long [1].”
Molecular genetics of prostate cancer: new prospects for old challenges. (2010, background): “In particular, patients with a Gleason pattern of 3 or less almost never relapse after local therapy, and very likely can be managed conservatively with ‘‘watchful waiting’’; nonetheless, a small fraction of these tumors will progress rapidly and require immediate treatment (Albertsen et al. 2005; E”